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It is well established that major depressive disorder (MDD) is
partly heritable. We present a genome-wide linkage study aiming
to find regions on the genome that influence the vulnerability for
MDD. Our sample consists of 110 Australian and 23 Dutch
pedigrees with two or more siblings affected with MDD (total
N¼ 278). Linkage analysis was carried out in MERLIN. Three
regions showed suggestive linkage signals. The highest LOD-
score of 2.1 was found on chromosome 17 at 52.6 cM along with
LOD scores of 1.9 and 1.7 on chromosome 8 at 2.7 cM and
chromosome 2 at 90.6 cM, respectively. The result on chromo-
some 8 seems most promising as two previous studies also found
linkage in this region, once suggestive and once significant. The
linkage peak on chromosome 17 harbors the serotonin trans-
porter gene. In the Australian and Dutch sample, the serotonin
transporter length polymorphism did not show evidence for
association, thus other genes in this region or other polymor-
phisms in the serotonin transporter gene might be associated
with MDD. Further replication is needed to establish the rele-
vance of our linkage finding on chromosome 2.2008 Wiley-Liss, Inc.
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INTRODUCTION
It is well established that major depressive disorder (MDD) is partly
heritable. A meta-analysis estimated the heritability of MDD
around 37% [Sullivan et al., 2000]. If measurement error due to
unreliability is taken into account by analyzing MDD assessed at
two occasions, the heritability estimate might be as high as 66%
[Foley et al., 1998]. These findings have led to attempts to identify
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genes influencing the vulnerability for MDD. As part of these
efforts, seven genome-wide linkage analyses have been performed,
aiming to locate genes for MDD on the genome [Nurnberger et al.,
2001; Zubenko et al., 2003; Holmans et al., 2004, 2007; Camp et al.,
2005; McGuffin et al., 2005]. Other studies have focused on
quantitative traits associated with a diagnosis of MDD, such as
neuroticism [Cloninger et al., 1998; Fullerton et al., 2003; Nash
et al., 2004; Neale et al., 2005; Kuo et al., 2007; Wray et al., 2008].
Table I summarizes the most promising results of these studies,
excluding the study of Holmans et al. [2004] as this is based on the
same sample as used by Holmans et al. [2007]. Several regions have
shown a linkage signal with an LOD-score>3 in at least one study.
The following five regions have reached an LOD-score >3 in one
study and an LOD-score >1.5 in a second study: chromosome 1
between 126 and 137 cM [Fullerton et al., 2003; Neale et al., 2005],
chromosome 8 between 8 and 38 cM [Cloninger et al., 1998;
Fullerton et al., 2003], chromosome 11 between 2 and 35 cM
[Zubenko et al., 2003; Camp et al., 2005], chromosome 11 between
85 and 99 cM [Fullerton et al., 2003; Zubenko et al., 2003] and
chromosome 12 between 105 and 124 cM [Fullerton et al., 2003;
McGuffin et al., 2005].
Five of these studies focused on phenotypes considered to be
most influenced by genetic factors, that is recurrent MDD
[McGuffin et al., 2005] or recurrent, early-onset MDD
[Zubenko et al., 2003; Holmans et al., 2004, 2007; Camp et al.,
2005]. This seemed a useful strategy to increase the chance to find
genes involved in MDD. However, comparing their results with the
linkage analysis of MDD [Nurnberger et al., 2001] or with the
additional linkage analysis of major mood disorders [Zubenko
et al., 2003] shows that this approach does not seem to result in
higher LOD scores than using a diagnosis of lifetime MDD.
Although Zubenko et al. [2003] have found the highest LOD score
for recurrent, early-onset and recurrent MDD, additional linkage
peaks were identified for major mood disorders.
We present a new linkage study of MDD performed on affected
sibling pairs selected from the Australian and Dutch Twin registers.
Although these samples are geographically disparate, we have
shown previously that the genetic distance between these Dutch
and Australian subjects (Fst¼ 0.30%) is comparable to that between
most Northern European populations [Sullivan et al., 2006]. Also,
the genetic architecture of MDD is similar in the two countries with
a heritability estimate for MDD of 36% and without evidence for sex
differences in genetic architecture, allowing us to pool data from
men and women in the linkage scan [Middeldorp et al., 2005].
MATERIALS AND METHODS
Subjects
Data were collected in the Australian and Netherlands Twin
Registers as part of a project aiming to find the genes underlying
the susceptibility to anxiety and MDD. Detailed descriptions of the
data collection have been published previously [Boomsma et al.,
TABLE I. Most Promising Linkage Results in the Order of the Chromosomes for Neuroticism, Harm Avoidance, MDD or the Subtypes
Recurrent MDD (R-MDD) and Recurrent Early-Onset MDD (RE-MDD)
Location (chromosome, cM) LOD N subjectsa/families Phenotype
1, 42, and 90 cM [Camp et al., 2005; Nash et al., 2004] 1.7 426/90 MDD-RE
1.6 711/283 Neuroticism
1, 126–137 cM [Fullerton et al., 2003; Neale et al., 2005] 4.0b 1,122/561 Neuroticism
2.5b 293/129 Neuroticism
2, 237–248 cM [Nurnberger et al., 2001; Zubenko et al., 2003] 2.2 224 possible pairs MDD comorbid with alcoholism
2.5b ?/81 MDD
4, 176 cM Fullerton et al. [2003] 3.8b 1,122/561 Neuroticism
7, 42 cM Fullerton et al. [2003] 3.9b 1,122/561 Neuroticism
8, 8–38 cM [Cloninger et al., 1998; Fullerton et al., 2003] 3.2 987/105 Harm avoidance
2.9b 1,122/561 Neuroticism
10, 5–9 cM [Camp et al., 2005; Wray et al., 2008] 1.6 426/90 RE-MDD
2.0 2,030/564 Neuroticism
10, 76 cM Zubenko et al. [2003] 3.0 ?/81 MDD
11, 2–35 cM [Camp et al., 2005; Zubenko et al., 2003] 1.6 426/90 RE-MDD and anxiety
4.2 ?/81 R-MDD
11, 85–99 cM [Fullerton et al., 2003; Zubenko et al., 2003] 3.7b 1,122/561 Neuroticism
2.5 ?/81 RE-MDD
12, 105–124 cM [Fullerton et al., 2003; McGuffin et al., 2005] 4.7b 1,122/561 Neuroticism
1.6 994/497 R-MDD
13, 64 cM Fullerton et al. [2003] 3.8b 1,122/561 Neuroticism
18, 73 cM Camp et al. [2005] 3.8 96/21 RE-MDD and anxiety
18, 109–117 cM [Cloninger et al., 1998; Wray et al., 2008] 1.6 987/105 Harm avoidance
1.9 8,552/2,509 Neuroticism
Regions with an LOD 3 or with an LOD 1.5 found at least twice are shown. Studies including subjects with bipolar disorder are excluded. Sex specific effects are not included.
aFor the MDD studies the number of affected individuals is given.
bThis is the log P, not the LOD score.
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2000; Kirk et al., 2000; Middeldorp et al., 2006]. In short, in 1998,
the most informative families for a linkage study on anxiety and/or
MDD were selected, based on survey data. Families were selected
with extreme scoring discordant (low–high) or concordant
(high–high and low–low) sib pairs on a quantitative scale that
correlates with a diagnosis of MDD [Eaves and Meyer, 1994; Risch
and Zhang, 1995; Dolan and Boomsma, 1998]. In Australia, the
selection variable was a normalized neuroticism score, adjusted for
age and sex, obtained in 1989. This score was available for 18,578
twins, siblings and adult offspring of twins [Kirk et al., 2000]. In
The Netherlands, the selection variable was a genetic factor
score expressing a subject’s genetic susceptibility to ‘‘anxious
depression.’’ Factor scores were calculated as a weighted sum of
the scores on four measures of neuroticism, anxiety, and depression
assessed on three different occasions (1991, 1993, and 1997). The
weights were derived from a multivariate genetic analysis and were
different for men and women [Boomsma et al., 2000]. A factor score
was available for 7,836 subjects [Middeldorp et al., 2006]. Extreme
discordant and concordant scoring sibling pairs were asked to
participate in a diagnostic psychiatric interview. In addition, other
offspring in these families, regardless of their value on the selection
variable, were invited to take part in the study.
In the Australian and Netherlands Twin Register, 2,918 and 1,517
subjects, respectively were approached to participate in the inter-
view. In Australia, 256 subjects declined and 192 could not be
contacted [Kirk et al., 2000]. In The Netherlands, 154 subjects
refused and 107 could not be contacted [Middeldorp et al., 2006]. In
total, 2,470 Australian and 1,256 Dutch individuals were inter-
viewed. Thus, a participation rate of around 90% was achieved in
both samples.
Genotyping was carried out in 1,943 subjects, including 737 men
and 1,206 women from Australia and 904 subjects, including
370 men and 534 women, from The Netherlands.
Genotyping
The genotypic data available for the Australian study resulted from
submission of DNA samples to one or more of six genotyping
centers, namely Gemini P/L (G), Sequana Therapeutics Inc. (S),
Leiden University Medical Center (L), the Center for Mammalian
Genetics at the Marshfield Clinic Research Foundation (M), the
Australian genotyping research facility (AGRF) (A), and the Finn-
ish Genome Center, University of Helsinki (H). A description of the
G, L, M, S genotyping and the subsequent merging and cleaning of
the marker data sets is described in detail elsewhere [Cornes et al.,
2005; Nyholt et al., 2005]. Since then, additional M, A, and H
genotypes have been merged using the same protocol. Family
members were submitted to the same genotyping facility. Data
cleaning based on Mendelian errors, unlikely genotypes and con-
sistency of pedigree and marker relationships was undertaken as
described by Cornes et al. [2005]. In brief, pedigree structures
for each scan were examined using graphic representation of
relationships (GRR) [Abecasis et al., 2001] and RELPAIR
[Epstein et al., 2000; Duren et al., 2003], to identify inconsistencies
between the genotypic data and pedigree relationships. Once any
discrepancies were resolved, data for the scans were merged and
then checked again for pedigree errors by GRR and for Mendelian
inconsistencies by SIB-PAIR [Duffy, 2002]. Duplicate markers in
the combined genome scan data were included separately on the
genetic map, separated by a very small distance (0.001 cM). The
consistency of genotype information between these duplicate
markers was checked via cross-tabulations of allele calls between
different scans. Markers with genotypic data inconsistent between
different genome scans were removed from further analysis. The
Mendelian error rate, counted as the number of genotypes removed
divided by total number of genotypes using all markers genotyped
in more than one lab was 0.57%. Unlikely genotypes were identified
and wiped using MERLIN [Abecasis et al., 2002]. Error rates were
similar for the different labs.
For the Dutch samples, DNA was extracted from either whole
blood or buccal swabs following standard protocols [Miller et al.,
1988; Meulenbelt et al., 1995]. Samples were genotyped by M and L.
The genotype data from these screens were combined. Allele calling
and binning were equalized between markers that were present in
multiple scans, using 30 control samples. In case there were
inconsistencies, the data were set to unknown for tested markers
(binning and allele calling inconsistencies) and persons
(genotyping errors). Sex and prior measured zygosity were checked
with the marker data. Pedigree relations in the entire samples were
checked with the GRR program [Abecasis et al., 2001]. Errors of
Mendelian inheritance were detected with Pedstats [Wigginton and
Abecasis, 2005]. Markers and samples were removed if their total
error rate was more than 1%; in all other cases the specific erroneous
genotypes were set as unknown. The mendelian error rate was
0.58%, Unlikely recombinants were detected using Merlin and
erroneous genotypes were removed with Pedwipe [Abecasis
et al., 2002]. Error rates were similar for the different labs.
Map positions of all genotyped markers were estimated in
Kosambi cM by locally weighted linear regression http://
www.qimr.edu.au/davidd from the NCBI Build 35.1 physical map
positions and published Decode and Marshfield genetic map
positions [Duffy, 2006]. Joint analysis of common markers geno-
typed in the Australian and Dutch samples estimated Fst between
the populations to be only 0.30% implying that these samples can be
combined for joint genetic analysis [Sullivan et al., 2006]. Individ-
uals were required to have genotypes on more than 280 markers
resulting in an average inter-marker distance of 8.2 cM (AU) and
9.6 cM (NL). The average number of markers genotyped in siblings
was 719 in the Australian sample (range 334–1,242) and 400 in the
Dutch sample (range 291–761).
Instruments
A telephone interview, during which the computerized version of
the composite international diagnostic interview (CIDI) [World
Health Organization, 1992] was administered to obtain lifetime
DSM-IV diagnoses of mood and anxiety disorders [American
Psychiatric Association, 1994]. The CIDI is a fully standardized
diagnostic interview. Good reliability and validity have been re-
ported for the CIDI [Andrews and Peters, 1998]. All interviewers
were trained by the Dutch and Australian World Health Organiza-
tion training centers. In order to minimize observer bias, inter-
viewers were unaware of interviewees’ status on the initial selection
variables throughout the study. The dependent variable used for
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linkage analysis was a lifetime diagnosis of MDD (DSM-IV codes:
296.21, 296.22, 296.23, 296.31, 296.32, and 296.33). Subjects who
might have experienced a (hypo)manic episode as measured with
the CIDI screening question (Australia) or the total ‘‘bipolar
disorder’’ section (The Netherlands) were excluded.
Statistical Analyses
Linkage analysis was carried out using MERLIN [Abecasis et al.,
2002]. Estimation of identity by descent (IBD) was based on the
allele frequencies in the total genotyped sample and additional
genotype data of family members of the affected siblings. Using the
Whittemore and Halpern NPL all statistic [Whittemore and Hal-
pern, 1994], MERLIN calculates at which markers affected siblings
share more alleles IBD than expected by chance. LOD scores are
calculated using the Kong and Cox linear model [Kong and Cox,
1997].
The 1-LOD-drop support interval was used as an estimate for the
90% confidence interval of any QTL locations [Abecasis et al., 2001]
and was used to examine linkage replication compared to previ-
ously reported locations (using Sullivan Lab Evidence Project
http://slep.unc.edu) and candidate genes (using Ensembl: www.
ensembl.org and OMIM: www.ncbi.nlm.nih.gov/entrez/query.
fcgi?db¼omim).
Empirically derived P values were calculated from 1,000 simu-
lated data sets using the gene-dropping method implemented in
MERLIN to calculate the threshold LOD-scores for suggestive and
significant linkage.
RESULTS
Mean age at the time of the interview was 43.1 years (SD 11.2) and
29.0 years (SD 11.2) for the 1,943 Australian subjects and the 904
Dutch subjects, respectively. Figure 1 shows that 110 Australian and
23 Dutch pedigrees included more than one affected sibling (total
N¼ 278 affected siblings), and thus were eligible for the linkage
analysis. From the families with two or more affected offspring,
genotypes were available on 35 fathers and 44 mothers and an
additional 130 siblings in the Australian sample and on 14 fathers
and 14 mothers and an additional 43 siblings in the Dutch sample.
Figure 2 shows the linkage results for the analysis of a lifetime
diagnosis of MDD and Table II shows the chromosomal regions
with an LOD score exceeding 1.0. Simulations yielded an empiri-
cally derived suggestive and significant LOD threshold of 1.66 and
2.95. Three regions showed suggestive linkage signals. The highest
LOD-score of 2.1 was found on chromosome 17 at 52.6 cm, marker
ATA58E08 (90% confidence interval: 46.6–62.5 cM bounded by
markers D17S921 and GGAA19G04). In addition, LOD scores of
1.9 and 1.7 were found on chromosome 8 at 2.7 cm, marker D8S504
(90% confidence interval: 0–12.4 cM, bounded by 8ptel and marker
D8S277) and chromosome 2 at 90.6 cM, marker GATA66D01
(90% confidence interval: 78.1–96.9 cM, bounded by markers
ATA27D04 and GATA181G08).
DISCUSSION
A linkage analysis on a combined Australian and Dutch sample
aiming to identify regions that might harbor genes influencing the
vulnerability for MDD found suggestive linkage for two new
regions on chromosome 2 and chromosome 17. In addition, we
found suggestive linkage on chromosome 8 in a region that showed
evidence for linkage in two previous studies, once significant and
once suggestive [Cloninger et al., 1998; Fullerton et al., 2003].
The region on chromosome 17 harbors the serotonin transporter
gene. In Dutch and Australian samples, partly overlapping with the
current samples, no evidence was found for an association with the
serotonin transporter gene length s/l polymorphism (5-HTTLPR)
and MDD (Dutch and Australian sample) or neuroticism and
symptoms of anxiety or depression (in the Dutch sample only)
[Gillespie et al., 2005; Middeldorp et al., 2007]. These findings
imply that another gene in this region is associated with MDD or
another polymorphism in the serotonin transporter gene, for
example, a recently identified third variant [Hu et al., 2006]. None
of the other usual candidate genes for major depression serotonin
receptor 1A (5HT1A), tryptophan hydroxylase (TPH) 1 and 2,
catechol-o-methyltransferase (COMT), or brain derived neuro-
trophic factor (BDNF) were found to lie under one of the linkage
peaks [Levinson, 2006].
None of the regions clearly overlapped with syntenic regions
found in linkage analyses on emotionality in mice, but the region on
FIG. 1. Number of Pedigrees (P) with and without affected (A) subjects for the Australian (left) and Dutch (right) samples. Printed in bold are the
number of pedigrees with the corresponding number of affected males (M) and females (F) which are included in the linkage analysis.
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chromosome 2 was very close, with 5 cM between the borders of the
confidence intervals [Smoller et al., 2001].
An important limitation of our study, as with many other linkage
studies of MDD (Table II), is the small sample size. A power analysis
performed in ASP [Krawczak, 2002] showed that we had 10%
power to find a P-value<0.001 (LOD score2) assuming a lifetime
prevalence of MDD of 15%. Therefore, it is likely that other regions
that are involved in the development of MDD were not identified.
Individual risk variants underlying complex genetic disease are
likely to explain only a fraction of the genetic variance [Welcome
Trust Case Control Consortium, 2007] but multiple risk variants
within a gene or chromosomal region may be more easily detected
by linkage than association, and consistently identified regions
from linkage analyses an be used to inform prioritization of results
from genome-wide association studies. In this study, we identified
three regions that exceeded the suggestive threshold for linkage,
defined as the threshold expected to be exceeded only once per
genome scan.
The current study was carried out in a sub-sample of a larger set
of families used for a linkage analysis of the mean neuroticism scores
over 4 (Australia) or 5 (The Netherlands) time points [Wray et al.,
2008]. Neuroticism is a personality trait measuring emotional
instability and those scoring highest on the neuroticism scale
express feelings of both anxiety and depression. The motivation
for the current study was greater phenotypic homogeneity despite
the loss of power in sample size. The three regions of suggestive
linkage identified in the neuroticism analysis (10p, 14q, and 18q)
showed no evidence for linkage in the current analysis of MDD,
although the linkage to 14q is most likely driven by anxiety
phenotypes in the Dutch sample [Middeldorp et al., 2008]. Of the
three regions identified in the current MDD linkage analysis,
chromosome 2 at 90 cM achieved LOD of 1 in the analysis of
neuroticism in the Dutch sample, but the regions on chromosomes
8 and 17 showed no evidence for linkage with mean neuroticism
score. However, the measure of neuroticism collected at the same
interview as the CIDI interview in the Australian sample (AU99)
did show evidence for linkage (LOD> 1) across the wide region of
0–85 cM on chromosome 17 [results for individual measures of
neuroticism were not presented in Wray et al., 2008], but not at
other time points.
To conclude, the region on chromosome 8 around 5 cM has
shown most evidence for harboring genes that are involved in the
development of MDD. Further research is warranted aiming to
identify the specific genes. Future studies are necessary to clarify the
significance of our finding on chromosome 2 and 17.
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